Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 1
2005 1
2006 5
2007 1
2008 2
2009 1
2010 2
2011 2
2012 4
2013 3
2014 1
2015 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Alendronate/colecalciferol.
Reynolds NA, Curran MP. Reynolds NA, et al. Treat Endocrinol. 2005;4(6):371-7; discussion 379. doi: 10.2165/00024677-200504060-00006. Treat Endocrinol. 2005. PMID: 16318403 Review.
The mean oral bioavailability of alendronate or colecalciferol is similar when administered alone or as one once-weekly tablet containing alendronate/colecalciferol 70 mg/2800 IU. In a 15-week, randomized, double-blind, multicenter study in patients wi …
The mean oral bioavailability of alendronate or colecalciferol is similar when administered alone or as one once-weekly tablet …
Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial.
Recker R, Lips P, Felsenberg D, Lippuner K, Benhamou L, Hawkins F, Delmas PD, Rosen C, Emkey R, Salzmann G, He W, Santora AC. Recker R, et al. Curr Med Res Opin. 2006 Sep;22(9):1745-55. doi: 10.1185/030079906x120913. Curr Med Res Opin. 2006. PMID: 16968578 Clinical Trial.
OBJECTIVE: Many osteoporosis patients have low 25-hydroxyvitamin D (25OHD) and do not take recommended vitamin D amounts. A single tablet containing both cholecalciferol (vitamin D3) and alendronate would improve vitamin D status concurrently, with a drug sho …
OBJECTIVE: Many osteoporosis patients have low 25-hydroxyvitamin D (25OHD) and do not take recommended vitamin D amounts. A single tablet co …
Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands.
Jansen JP, Gaugris S, Bergman G, Sen SS. Jansen JP, et al. Curr Med Res Opin. 2008 Mar;24(3):671-84. doi: 10.1185/030079908X260998. Epub 2008 Jan 24. Curr Med Res Opin. 2008. PMID: 18221588
OBJECTIVE: To evaluate the cost-effectiveness of a fixed dose combination of alendronate 70 mg and cholecalciferol 2800 IU (alendronate/vitamin D3; Fosavance) versus no treatment, alendronate with dietary vitamin D supplements and ibandronate in the tr …
OBJECTIVE: To evaluate the cost-effectiveness of a fixed dose combination of alendronate 70 mg and cholecalciferol 2800 IU ( …
Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females.
Mok JO, Jung CH, Kim CH, Ryu CB, Kim YJ, Kim SJ, Park HK, Suh KI, Yoo MH, Byun DW. Mok JO, et al. Korean J Intern Med. 2013 Nov;28(6):694-700. doi: 10.3904/kjim.2013.28.6.694. Epub 2013 Oct 29. Korean J Intern Med. 2013. PMID: 24307845 Free PMC article. Clinical Trial.
BACKGROUND/AIMS: This study was performed to compare the mucosal findings after esophagogastroduodenoscopy in two groups before and after the use of alendronate only and following administration of the enteric-coated alendronate (5 mg) and calcitriol (0.5 g) combine …
BACKGROUND/AIMS: This study was performed to compare the mucosal findings after esophagogastroduodenoscopy in two groups before and after th …
Combined therapies in osteoporosis: bisphosphonates and vitamin D-hormone analogs.
Schacht E, Dukas L, Richy F. Schacht E, et al. J Musculoskelet Neuronal Interact. 2007 Apr-Jun;7(2):174-84. J Musculoskelet Neuronal Interact. 2007. PMID: 17627088 Free article. Review.
A growing amount of data documents the pre-clinical and clinical efficacies of combinations of bisphosphonates with calcitriol, or with alfacalcidol in primary and secondary osteoporosis. ...As a investigated by most of the currently available trials, a daily dose of al …
A growing amount of data documents the pre-clinical and clinical efficacies of combinations of bisphosphonates with calcitriol, or wi …
Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
Cesareo R, Di Stasio E, Vescini F, Campagna G, Cianni R, Pasqualini V, Romitelli F, Grimaldi F, Manfrini S, Palermo A. Cesareo R, et al. Osteoporos Int. 2015 Apr;26(4):1295-302. doi: 10.1007/s00198-014-3000-2. Epub 2014 Dec 19. Osteoporos Int. 2015. PMID: 25524023 Clinical Trial.
METHODS: The study was a prospective open label randomized trial comparing 15 postmenopausal women with NPHPT (PMW-NPHPT), treated with oral alendronate plus cholecalciferol (treated group) and 15 PMW-NPHPT treated only with cholecalciferol (control group). . …
METHODS: The study was a prospective open label randomized trial comparing 15 postmenopausal women with NPHPT (PMW-NPHPT), treated with oral …
Improved dosage form of the combined alendronate and calcitriol (Maxmarvil) on the absorption of alendronate in Korean postmenopausal women.
Chung YS, Choi YJ, Kim SH. Chung YS, et al. Arch Pharm Res. 2013 Aug;36(8):966-72. doi: 10.1007/s12272-013-0124-4. Epub 2013 May 17. Arch Pharm Res. 2013. PMID: 23681426 Clinical Trial.
Alendronate is one of the most potent anti-osteoporotic agents for postmenopausal osteoporosis. ...Recently, Maxmarvil was developed as an enteric-coated tablet containing alendronate (5 mg) and calcitriol (0.5 mug) to minimize these side effects of alendronate …
Alendronate is one of the most potent anti-osteoporotic agents for postmenopausal osteoporosis. ...Recently, Maxmarvil was developed …
Bioavailability of alendronate and vitamin D(3) in an alendronate/vitamin D(3) combination tablet.
Denker AE, Lazarus N, Porras A, Ramakrishnan R, Constanzer M, Scott BB, Chavez-Eng C, Woolf E, Maganti L, Larson P, Gottesdiener K, Wagner JA. Denker AE, et al. J Clin Pharmacol. 2011 Oct;51(10):1439-48. doi: 10.1177/0091270010382010. Epub 2010 Dec 8. J Clin Pharmacol. 2011. PMID: 21148044 Clinical Trial.
These studies were designed to demonstrate that the alendronate (ALN) component of an ALN/vitamin D(3) combination tablet was bioequivalent to the 70-mg ALN tablet and that the pharmacokinetic parameters of vitamin D(3) were similar with or without ALN. ...
These studies were designed to demonstrate that the alendronate (ALN) component of an ALN/vitamin D(3) combination tablet was bioequi …
Calcitriol and alendronate combination treatment in menopausal women with low bone mass.
Malavolta N, Zanardi M, Veronesi M, Ripamonti C, Gnudi S. Malavolta N, et al. Int J Tissue React. 1999;21(2):51-9. Int J Tissue React. 1999. PMID: 10568224 Clinical Trial.
The first group was treated every other day with 0.25 microgram of synthetic 1,25-dihydroxyvitamin D3 plus 10 mg alendronate. The second group received the same dose of alendronate plus calcium (500 mg/day). ...The effects of both combinations on bone mass ar …
The first group was treated every other day with 0.25 microgram of synthetic 1,25-dihydroxyvitamin D3 plus 10 mg alendronate. The sec …
Effect of preoperative combined treatment with alendronate and calcitriol on fixation of hydroxyapatite-coated implants in ovariectomized rats.
Nakamura Y, Hayashi K, Abu-Ali S, Naito M, Fotovati A. Nakamura Y, et al. J Bone Joint Surg Am. 2008 Apr;90(4):824-32. doi: 10.2106/JBJS.G.00635. J Bone Joint Surg Am. 2008. PMID: 18381321
RESULTS: Although total bone mineral density increased in all of the alendronate-treated groups, compared with that in the ovariectomized control group, cancellous bone mineral density increased only in the group pretreated with both alendronate and calcitriol. The …
RESULTS: Although total bone mineral density increased in all of the alendronate-treated groups, compared with that in the ovariectom …
23 results